BioSpace News Archive

AHEAD Study, the first trial that aims to help prevent Alzheimer’s disease, is recruiting participants as young as 55 at risk for dementia and using a new personalized medicine approach Study launched during World Alzheimer’s Month [22-September-2020] SAN DIEGO , Sept. 22, 2020 /PRNewswire/ -- The first infusion of an investigational drug that aims to delay

The National Association of Chronic Disease Directors is proud to announce the winners of this year’s prestigious Impact Awards, announced during the Association’s Annual Business Meeting.

Lumenis Inc., the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, is proud to announce its first-ever mobile tour, September 28th through April 2021.

Today, Sanofi and GSK announce the signing of agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19 vaccine, beginning in 2021.

RTI Surgical recently received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) for the Dynamic Active Compression (DAC) Plate to provide stabilization and fixation of small bones of the foot.

At the onset of the pandemic the nation began to practice social distancing, and subsequently, many stopped scheduling visits with their doctors. Laboratories like Premier Medical Laboratory Services suddenly pivoted much of their efforts into providing a high volume of testing for COVID-19. Now, as more businesse

Today, the U.S. Food and Drug Administration announced it is launching the Digital Health Center of Excellence within the Center for Devices and Radiological Health (CDRH). The launch of the Digital Health Center of Excellence is an important step in furthering the agency’s overarching dedication to the advancement of digi

P360, a leading developer of technology for life sciences companies, has announced major updates to its sales enablement platform BirdzAI.

Wave Life Sciences Ltd., a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced that it has commenced an underwritten public offering of its ordinary shares.

Management presentation Wednesday, September 23 at 10:50 a.m. EDT